HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice.

Abstract
The RNA-specific cytidine deaminase apobec-1 is an AU-rich RNA binding protein that binds the 3' untranslated region (UTR) of cyclooxygenase-2 (Cox-2) mRNA and stabilizes its turnover in vitro. Cox-2 overexpression accompanies intestinal adenoma formation in both humans and mice. Evidence from both genetic deletion studies as well as from pharmacologic inhibition has implicated Cox-2 in the development of intestinal adenomas in experimental animals and in adenomas and colorectal cancer in humans. Here, we show that small intestinal adenoma formation is dramatically reduced in compound Apc(min/+) apobec-1(-/-) mice when compared with the parental Apc(min/+) strain. This reduced tumor burden was found in association with increased small intestinal apoptosis and reduced proliferation in small intestinal crypt-villus units from compound Apc(min/+) apobec-1(-/-) mice. Intestinal adenomas from compound Apc(min/+) apobec-1(-/-) mice showed a <2-fold increase in Cox-2 mRNA abundance and reduced prostaglandin E(2) content compared with adenomas from the parental Apc(min/+) strain. In addition, there was reduced expression in adenomas from compound Apc(min/+) apobec-1(-/-) mice of other mRNAs (including epidermal growth factor receptor, peroxisome proliferator-activated receptor delta, prostaglandin receptor EP4, and c-myc), each containing the apobec-1 consensus binding site within their 3'-UTR. Adenovirus-mediated apobec-1 introduction into HCA-7 (colorectal cancer) cells showed a dose-dependent increase in Cox-2 protein and stabilization of endogenous Cox-2 mRNA. These findings suggest that deletion of apobec-1, by modulating expression of AU-rich RNA targets, provides an important mechanism for attenuating a dominant genetic restriction point in intestinal adenoma formation.
AuthorsValerie Blanc, Jeffrey O Henderson, Rodney D Newberry, Yan Xie, Soo-Jin Cho, Elizabeth P Newberry, Susan Kennedy, Deborah C Rubin, Hanlin L Wang, Jianyang Luo, Nicholas O Davidson
JournalCancer research (Cancer Res) Vol. 67 Issue 18 Pg. 8565-73 (Sep 15 2007) ISSN: 0008-5472 [Print] United States
PMID17875695 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • RNA, Messenger
  • Cyclooxygenase 2
  • APOBEC-1 Deaminase
  • APOBEC1 protein, human
  • Apobec1 protein, mouse
  • Cytidine Deaminase
Topics
  • APOBEC-1 Deaminase
  • Adenoma (enzymology, genetics)
  • Animals
  • Colorectal Neoplasms (genetics, metabolism)
  • Cyclooxygenase 2 (biosynthesis, genetics)
  • Cytidine Deaminase (biosynthesis, deficiency, genetics)
  • Genes, APC
  • Humans
  • Intestinal Neoplasms (enzymology, genetics)
  • Intestine, Small (pathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • RNA, Messenger (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: